|
|
Blood, 15 February 2004, Vol. 103, No. 4, pp. 1348-1355.
Prepublished online as a Blood First Edition Paper on October 23, 2003; DOI 10.1182/blood-2003-06-1781.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1
Nicolas Prévost,
Donna S. Woulfe,
Massimiliano Tognolini,
Takako Tanaka,
Wenying Jian,
Ryan R. Fortna,
Hong Jiang, and
Lawrence F. Brass
From the Departments of Medicine and Pharmacology and the Center for Experimental Therapeutics at the University of Pennsylvania, Philadelphia, PA.
We have previously shown that platelets express 2 receptor tyrosine kinases, EphA4 and EphB1, and the Eph kinase ligand, ephrinB1, and proposed that transcellular Eph/ephrin interactions made possible by the onset of platelet aggregation promote the further growth and stability of the hemostatic plug. The present study examines how this might occur. The results show that clustering of either ephrinB1 or EphA4 causes platelets to adhere to immobilized fibrinogen via IIb 3. Adhesion occurs more slowly than with adenosine diphosphate (ADP) and requires phosphatidylinositol 3 (PI3)kinase and protein kinase C activity but not ephrinB1 phosphorylation. By itself, Eph and ephrin signaling is insufficient to cause aggregation or the binding of soluble fibrinogen, but it can potentiate aggregation initiated by a Ca++ ionophore or by agonists for thrombin and thromboxane receptors. It also enhances Rap1 activation without requiring ADP secretion, ephrinB1 phosphorylation, or the activation of PI3-kinase and Src. From this we conclude that (1) Eph/ephrin signaling enhances the ability of platelet agonists to cause aggregation provided that those agonists can increase cytosolic Ca++; (2) this is accomplished in part by activating Rap1; and (3) these effects require oligomerization of ephrinB1 but not phosphotyrosine-based interactions with the ephrinB1 cytoplasmic domain.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. F. Brass, L. Zhu, and T. J. Stalker
Novel Therapeutic Targets at the Platelet Vascular Interface
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2008;
28(3):
s43 - s50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Arvanitis and A. Davy
Eph/ephrin signaling: networks
Genes & Dev.,
February 15, 2008;
22(4):
416 - 429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jiang, T. Freywald, J. Webster, D. Kozan, R. Geyer, J. DeCoteau, A. Narendran, and A. Freywald
In Human Leukemia Cells Ephrin-B-Induced Invasive Activity Is Supported by Lck and Is Associated with Reassembling of Lipid Raft Signaling Complexes
Mol. Cancer Res.,
February 1, 2008;
6(2):
291 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pfaff, U. Fiedler, and H. G. Augustin
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking
J. Leukoc. Biol.,
October 1, 2006;
80(4):
719 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yu, J. Mao, Y. Wu, H. Luo, and J. Wu
Ephrin-B1 Is Critical in T-cell Development
J. Biol. Chem.,
April 14, 2006;
281(15):
10222 - 10229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nanda, P. Andre, M. Bao, K. Clauser, F. Deguzman, D. Howie, P. B. Conley, C. Terhorst, and D. R. Phillips
Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling
Blood,
November 1, 2005;
106(9):
3028 - 3034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Prevost, D. S. Woulfe, H. Jiang, T. J. Stalker, P. Marchese, Z. M. Ruggeri, and L. F. Brass
Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets
PNAS,
July 12, 2005;
102(28):
9820 - 9825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Serini and F. Bussolino
Common Cues in Vascular and Axon Guidance
Physiology,
December 1, 2004;
19(6):
348 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|